Ceptur Therapeutics Overview
- Year Founded
-
2008

- Status
-
Private
- Employees
-
6

- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$75M
- Investors
-
11
Ceptur Therapeutics General Information
Description
Developer of U1 adaptor technology designed to facilitate the creation of treatment. The company's technology overcomes the limitations of gene silencing technologies and offers cancer treatment, enabling doctors to treat patients with various types of cancers.
Contact Information
Website
www.cepturtx.comCorporate Office
- 1 Ilene Court, Building 8
- Suite 9
- Hillsborough, NJ 08844
- United States
Corporate Office
- 1 Ilene Court, Building 8
- Suite 9
- Hillsborough, NJ 08844
- United States
Ceptur Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Later Stage VC (Series A) | 19-Jan-2022 | $75M | Completed | Generating Revenue | ||
2. Seed Round | 13-Aug-2020 | Completed | Clinical Trials - Phase 1 | |||
1. Grant | 01-Jan-2010 | $189K | Completed | Startup |
Ceptur Therapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Ceptur Therapeutics Comparisons
Industry
Financing
Details
Ceptur Therapeutics Competitors (3)
One of Ceptur Therapeutics’s 3 competitors is GeneCentric, a Venture Capital-Backed company based in NC.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
GeneCentric | Venture Capital-Backed | NC | ||||
ReviR Therapeutics | Venture Capital-Backed | Brisbane, CA | ||||
Arrakis Therapeutics | Venture Capital-Backed | Waltham, MA |
Ceptur Therapeutics Patents
Ceptur Therapeutics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3946375-A1 | Compositions and methods for treating neurodegenerative disorders | Inactive | 26-Mar-2019 | ||
AU-2020248392-A1 | Compositions and methods for treating neurodegenerative disorders | Inactive | 26-Mar-2019 | ||
US-20220372488-A1 | Compositions and methods for treating neurodegenerative disorders | Pending | 26-Mar-2019 | ||
CA-3134683-A1 | Compositions and methods for treating neurodegenerative disorders | Pending | 26-Mar-2019 | ||
EP-3935167-A2 | Compositions and methods for treating huntington's disease | Inactive | 08-Mar-2019 | C12N15/113 |
Ceptur Therapeutics Signals
Ceptur Therapeutics Investors (11)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Bristol-Myers Squibb | Corporation | Minority | ||
Janus Henderson Investors | Asset Manager | Minority | ||
Perceptive Advisors | Venture Capital | Minority | ||
Qiming Venture Partners USA | Venture Capital | Minority | ||
venBio | Venture Capital | Minority |
Ceptur Therapeutics FAQs
-
When was Ceptur Therapeutics founded?
Ceptur Therapeutics was founded in 2008.
-
Where is Ceptur Therapeutics headquartered?
Ceptur Therapeutics is headquartered in Hillsborough, NJ.
-
What is the size of Ceptur Therapeutics?
Ceptur Therapeutics has 6 total employees.
-
What industry is Ceptur Therapeutics in?
Ceptur Therapeutics’s primary industry is Drug Discovery.
-
Is Ceptur Therapeutics a private or public company?
Ceptur Therapeutics is a Private company.
-
What is Ceptur Therapeutics’s current revenue?
The current revenue for Ceptur Therapeutics is
. -
How much funding has Ceptur Therapeutics raised over time?
Ceptur Therapeutics has raised $81.2M.
-
Who are Ceptur Therapeutics’s investors?
Bristol-Myers Squibb, Janus Henderson Investors, Perceptive Advisors, Qiming Venture Partners USA, and venBio are 5 of 11 investors who have invested in Ceptur Therapeutics.
-
Who are Ceptur Therapeutics’s competitors?
GeneCentric, ReviR Therapeutics, and Arrakis Therapeutics are competitors of Ceptur Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »